Speeches, Articles and Testimony by

LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Kevin Wright, HCG Platinum, LLC

LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Clint Ethington, HCG Diet Direct LLC

LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Richard Matmer, Nutri Fusion Systems LLC

LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Greg Grimshaw, hcg-miracleweightloss.com

LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Richard Matmer, Nutri Fusion Systems LLC

Resolution of NAD referral

Before the Subcommittee on Commerce, Manufacturing, and Trade, and the Subcommittee on Health of the Committee on Energy and Commerce, United States House of Representatives

Before the Subcommittee on Commerce, Manufacturing, and Trade of the Committee on Energy and Commerce, United States House of Representatives